ERBB2 and colorectal carcinoma: Dosing of the NCI 135848-042-T CRC xenografts, which additionally harbor mutations in mTOR (S2215F) and ERBB2 (S310F), was curtailed to 10 days owing to >10% body weight loss in control animals.